Your Access
Your Access

Aimovig® free

for up to 12 monthly doses1

or

$5 copay per month2

Your Access

*Copay Offer and Bridge to Commercial Coverage Offer fulfillment dependent on pharmacy election to process Aimovig Ally access card based on program terms and conditions. Aimovig Ally cannot guarantee fulfillment by any particular pharmacy.

  1. If the patient's health plan does not cover Aimovig®, or requires a prior authorization, the patient can qualify for the Bridge to Commercial Coverage offer and receive Aimovig® free for up to 12 doses, while pursuing approval from their health plan. No purchase necessary. Please see the full Terms and Conditions below.
  2. If approved by the patient's health plan to take Aimovig®, a patient pays a $5 copay per month, up to a maximum benefit of $3500 annually. This applies to patient out-of-pocket costs, including deductible, co-insurance, and copayments for Aimovig®. Patient is responsible for costs above the annual maximum. Please see the full Terms and Conditions below.

*Copay Offer and Bridge to Commercial Coverage Offer fulfillment dependent on pharmacy election to process Aimovig Ally access card based on program terms and conditions. Aimovig Ally cannot guarantee fulfillment by any particular pharmacy.

Enroll or activate the Aimovig Ally Access Card Program. You can also sign up for our patient support services and receive helpful resources.
For eligible commercially insured patients. Not available for patients receiving coverage under any federal-, state-, or government-funded healthcare program.
Re-enrollment in the Aimovig Ally Access Card is required every 12 months. If your enrollment is due to expire, please click this button to re-enroll for an additional 12 months.

If you have questions, simply call our Aimovig Ally support team at 833-AIMOVIG (833-246-6844), Monday - Friday, 8 am - 11 pm ET.

For more information about Aimovig® please visit: aimovig.com  | Privacy Policy  | Terms of Use

For more information about Aimovig please visit:   aimovig.com  | Privacy Policy  | Terms of Use

+

Important Safety Information

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including: allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® (erenumab-aooe) is a prescription medicine used for the preventive treatment of migraine in adults.

  

© 2019 Amgen Inc. All rights reserved.

Amgen Inc.
One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080                                                   




© 2019 Amgen Inc. All rights reserved.

Amgen Inc. One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080